



# 1. Sensitivity Analysis


## 1.1. Sensitivity Analysis for Raltegravir 10 mg (lactose formulation)


\newpage
Figure 1: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 2: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 3: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 4: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 5: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 6: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 7: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 8: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 9: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 10: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%2010%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.2. Sensitivity Analysis for Raltegravir 25 mg (lactose formulation)


\newpage
Figure 11: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 12: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 13: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 14: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 15: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 16: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 17: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 18: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 19: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 20: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%2025%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.3. Sensitivity Analysis for Raltegravir 50 mg (lactose formulation)


\newpage
Figure 21: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 22: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 23: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 24: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 25: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 26: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 27: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 28: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 29: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 30: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%2050%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.4. Sensitivity Analysis for Raltegravir 100 mg (lactose formulation)


\newpage
Figure 31: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 32: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 33: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 34: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 35: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 36: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 37: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 38: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 39: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 40: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.5. Sensitivity Analysis for Raltegravir 200 mg (lactose formulation)


\newpage
Figure 41: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 42: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 43: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 44: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 45: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 46: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 47: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 48: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 49: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 50: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.6. Sensitivity Analysis for Raltegravir 400mg (lactose formulation)


\newpage
Figure 51: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 52: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 53: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 54: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 55: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 56: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 57: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 58: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 59: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 60: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.7. Sensitivity Analysis for Raltegravir 800 mg (lactose formulation)


\newpage
Figure 61: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 62: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 63: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 64: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 65: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 66: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 67: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 68: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 69: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 70: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%20800%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.8. Sensitivity Analysis for Raltegravir 1200 mg (lactose formulation)


\newpage
Figure 71: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 72: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 73: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 74: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 75: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 76: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 77: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 78: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 79: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 80: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%201200%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.9. Sensitivity Analysis for Raltegravir 1600 mg (lactose formulation)


\newpage
Figure 81: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 82: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 83: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 84: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 85: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 86: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 87: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 88: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 89: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 90: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%201600%20mg%20(lactose%20formulation)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.10. Sensitivity Analysis for Raltegravir 100 mg filmcoated tablet md


\newpage
Figure 91: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 92: Most sensitive parameters for C_max_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-C_max_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 93: Most sensitive parameters for C_max_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-C_max_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 94: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 95: Most sensitive parameters for t_max_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-t_max_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 96: Most sensitive parameters for t_max_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-t_max_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 97: Most sensitive parameters for C_trough_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-C_trough_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 98: Most sensitive parameters for C_trough_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-C_trough_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 99: Most sensitive parameters for AUC_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-AUC_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 100: Most sensitive parameters for AUC_tLast_minus_1_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-AUC_tDLast_minus_1_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 101: Most sensitive parameters for AUC_inf_t1 of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-AUC_inf_tD1-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 102: Most sensitive parameters for AUC_inf_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-AUC_inf_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 103: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 104: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 105: Most sensitive parameters for Thalf_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-Thalf_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.11. Sensitivity Analysis for Raltegravir 200 mg filmcoated tablet md


\newpage
Figure 106: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 107: Most sensitive parameters for C_max_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-C_max_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 108: Most sensitive parameters for C_max_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-C_max_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 109: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 110: Most sensitive parameters for t_max_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-t_max_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 111: Most sensitive parameters for t_max_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-t_max_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 112: Most sensitive parameters for C_trough_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-C_trough_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 113: Most sensitive parameters for C_trough_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-C_trough_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 114: Most sensitive parameters for AUC_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-AUC_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 115: Most sensitive parameters for AUC_tLast_minus_1_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-AUC_tDLast_minus_1_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 116: Most sensitive parameters for AUC_inf_t1 of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-AUC_inf_tD1-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 117: Most sensitive parameters for AUC_inf_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-AUC_inf_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 118: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 119: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 120: Most sensitive parameters for Thalf_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-Thalf_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.12. Sensitivity Analysis for Filmcoated_tablet_400mg_sd


\newpage
Figure 121: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 122: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 123: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 124: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 125: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 126: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 127: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 128: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 129: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 130: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Filmcoated_tablet_400mg_sd-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.13. Sensitivity Analysis for Raltegravir 400 mg filmcoated tablet md


\newpage
Figure 131: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 132: Most sensitive parameters for C_max_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-C_max_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 133: Most sensitive parameters for C_max_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-C_max_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 134: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 135: Most sensitive parameters for t_max_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-t_max_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 136: Most sensitive parameters for t_max_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-t_max_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 137: Most sensitive parameters for C_trough_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-C_trough_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 138: Most sensitive parameters for C_trough_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-C_trough_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 139: Most sensitive parameters for AUC_t1_t2 of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-AUC_tD1_tD2-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 140: Most sensitive parameters for AUC_tLast_minus_1_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-AUC_tDLast_minus_1_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 141: Most sensitive parameters for AUC_inf_t1 of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-AUC_inf_tD1-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 142: Most sensitive parameters for AUC_inf_tLast of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-AUC_inf_tDLast-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 143: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 144: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 145: Most sensitive parameters for Thalf_tLast_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-Thalf_tDLast_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.14. Sensitivity Analysis for Raltegravir 400mg chewable fasted


\newpage
Figure 146: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 147: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 148: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 149: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 150: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 151: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 152: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 153: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 154: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 155: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fasted-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.15. Sensitivity Analysis for Raltegravir 400mg chewable fed


\newpage
Figure 156: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 157: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 158: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 159: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 160: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 161: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 162: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 163: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 164: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 165: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20chewable%20fed-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)


## 1.16. Sensitivity Analysis for Raltegravir 400mg (granules in suspension)


\newpage
Figure 166: Most sensitive parameters for C_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-C_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 167: Most sensitive parameters for t_max of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-t_max-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 168: Most sensitive parameters for C_tEnd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-C_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 169: Most sensitive parameters for AUC of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-AUC_tEnd-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 170: Most sensitive parameters for AUC_inf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-AUC_inf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 171: Most sensitive parameters for MRT of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-MRT-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 172: Most sensitive parameters for Thalf of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-Thalf-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 173: Most sensitive parameters for CL of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-CL-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 174: Most sensitive parameters for Vss of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-Vss-Plasma%20(Peripheral%20Venous%20Blood).png)


\newpage
Figure 175: Most sensitive parameters for Vd of Raltegravir.


![](Sensitivity/Raltegravir%20400mg%20(granules%20in%20suspension)-Vd-Plasma%20(Peripheral%20Venous%20Blood).png)





# 2. PK parameters


## 2.1. PK parameters for Raltegravir 10 mg (lactose formulation)


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        |  110.4938945|µg/l      |
|Raltegravir |C_max_norm   |    0.8066055|kg/l      |
|Raltegravir |t_max        |    0.7500000|h         |
|Raltegravir |C_tEnd       |    1.9563139|µg/l      |
|Raltegravir |AUC          |  241.6052506|µg*h/l    |
|Raltegravir |AUC_norm     |    1.7637182|kg*h/l    |
|Raltegravir |AUC_inf      |  255.1373571|µg*h/l    |
|Raltegravir |AUC_inf_norm |    1.8625028|kg*h/l    |
|Raltegravir |MRT          |    3.3293592|h         |
|Raltegravir |Thalf        |    4.7946014|h         |
|Raltegravir |CL           |    8.9485329|ml/min/kg |
|Raltegravir |Vss          | 1787.5727415|ml/kg     |
|Raltegravir |Vd           | 3713.8993740|ml/kg     |


## 2.2. PK parameters for Raltegravir 25 mg (lactose formulation)


|Path        |Parameter    |       Value|Unit      |
|:-----------|:------------|-----------:|:---------|
|Raltegravir |C_max        |  276.849301|µg/l      |
|Raltegravir |C_max_norm   |    0.808400|kg/l      |
|Raltegravir |t_max        |    0.750000|h         |
|Raltegravir |C_tEnd       |    4.894139|µg/l      |
|Raltegravir |AUC          |  605.060435|µg*h/l    |
|Raltegravir |AUC_norm     |    1.766776|kg*h/l    |
|Raltegravir |AUC_inf      |  638.895505|µg*h/l    |
|Raltegravir |AUC_inf_norm |    1.865575|kg*h/l    |
|Raltegravir |MRT          |    3.327076|h         |
|Raltegravir |Thalf        |    4.791995|h         |
|Raltegravir |CL           |    8.933796|ml/min/kg |
|Raltegravir |Vss          | 1783.405542|ml/kg     |
|Raltegravir |Vd           | 3705.768108|ml/kg     |


## 2.3. PK parameters for Raltegravir 50 mg (lactose formulation)


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        |  556.5980647|µg/l      |
|Raltegravir |C_max_norm   |    0.8126331|kg/l      |
|Raltegravir |t_max        |    0.7500000|h         |
|Raltegravir |C_tEnd       |    1.5273094|µg/l      |
|Raltegravir |AUC          | 1296.6529555|µg*h/l    |
|Raltegravir |AUC_norm     |    1.8931133|kg*h/l    |
|Raltegravir |AUC_inf      | 1317.0860058|µg*h/l    |
|Raltegravir |AUC_inf_norm |    1.9229455|kg*h/l    |
|Raltegravir |MRT          |    4.1443451|h         |
|Raltegravir |Thalf        |    9.2732239|h         |
|Raltegravir |CL           |    8.6672585|ml/min/kg |
|Raltegravir |Vss          | 2155.2066803|ml/kg     |
|Raltegravir |Vd           | 6957.2610855|ml/kg     |


## 2.4. PK parameters for Raltegravir 100 mg (lactose formulation)


|Path        |Parameter    |       Value|Unit      |
|:-----------|:------------|-----------:|:---------|
|Raltegravir |C_max        | 1123.897267|µg/l      |
|Raltegravir |C_max_norm   |    0.820445|kg/l      |
|Raltegravir |t_max        |    0.750000|h         |
|Raltegravir |C_tEnd       |    2.836519|µg/l      |
|Raltegravir |AUC          | 2615.773112|µg*h/l    |
|Raltegravir |AUC_norm     |    1.909514|kg*h/l    |
|Raltegravir |AUC_inf      | 2654.063466|µg*h/l    |
|Raltegravir |AUC_inf_norm |    1.937466|kg*h/l    |
|Raltegravir |MRT          |    4.138122|h         |
|Raltegravir |Thalf        |    9.356846|h         |
|Raltegravir |CL           |    8.602300|ml/min/kg |
|Raltegravir |Vss          | 2135.842085|ml/kg     |
|Raltegravir |Vd           | 6967.385769|ml/kg     |


## 2.5. PK parameters for Raltegravir 200 mg (lactose formulation)


|Path        |Parameter    |       Value|Unit      |
|:-----------|:------------|-----------:|:---------|
|Raltegravir |C_max        | 2283.843895|µg/l      |
|Raltegravir |C_max_norm   |    0.833603|kg/l      |
|Raltegravir |t_max        |    0.750000|h         |
|Raltegravir |C_tEnd       |    1.918062|µg/l      |
|Raltegravir |AUC          | 5349.761122|µg*h/l    |
|Raltegravir |AUC_norm     |    1.952663|kg*h/l    |
|Raltegravir |AUC_inf      | 5376.252319|µg*h/l    |
|Raltegravir |AUC_inf_norm |    1.962332|kg*h/l    |
|Raltegravir |MRT          |    4.134027|h         |
|Raltegravir |Thalf        |    9.573441|h         |
|Raltegravir |CL           |    8.493296|ml/min/kg |
|Raltegravir |Vss          | 2106.690645|ml/kg     |
|Raltegravir |Vd           | 7038.337707|ml/kg     |


## 2.6. PK parameters for Raltegravir 400mg (lactose formulation)


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        |  4673.726268|µg/l      |
|Raltegravir |C_max_norm   |     0.852955|kg/l      |
|Raltegravir |t_max        |     0.750000|h         |
|Raltegravir |C_tEnd       |     3.837874|µg/l      |
|Raltegravir |AUC          | 10899.606324|µg*h/l    |
|Raltegravir |AUC_norm     |     1.989178|kg*h/l    |
|Raltegravir |AUC_inf      | 10952.620364|µg*h/l    |
|Raltegravir |AUC_inf_norm |     1.998853|kg*h/l    |
|Raltegravir |MRT          |     4.109855|h         |
|Raltegravir |Thalf        |     9.574743|h         |
|Raltegravir |CL           |     8.338114|ml/min/kg |
|Raltegravir |Vss          |  2056.106567|ml/kg     |
|Raltegravir |Vd           |  6910.678864|ml/kg     |


## 2.7. PK parameters for Raltegravir 800 mg (lactose formulation)


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        | 9.613040e+03|µg/l      |
|Raltegravir |C_max_norm   | 8.771899e-01|kg/l      |
|Raltegravir |t_max        | 7.500000e-01|h         |
|Raltegravir |C_tEnd       | 6.643868e+00|µg/l      |
|Raltegravir |AUC          | 2.234232e+04|µg*h/l    |
|Raltegravir |AUC_norm     | 2.038736e+00|kg*h/l    |
|Raltegravir |AUC_inf      | 2.243378e+04|µg*h/l    |
|Raltegravir |AUC_inf_norm | 2.047083e+00|kg*h/l    |
|Raltegravir |MRT          | 4.084571e+00|h         |
|Raltegravir |Thalf        | 9.542753e+00|h         |
|Raltegravir |CL           | 8.141668e+00|ml/min/kg |
|Raltegravir |Vss          | 1.995313e+03|ml/kg     |
|Raltegravir |Vd           | 6.725318e+03|ml/kg     |


## 2.8. PK parameters for Raltegravir 1200 mg (lactose formulation)


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        | 1.468291e+04|µg/l      |
|Raltegravir |C_max_norm   | 8.932101e-01|kg/l      |
|Raltegravir |t_max        | 7.500000e-01|h         |
|Raltegravir |C_tEnd       | 1.997039e+00|µg/l      |
|Raltegravir |AUC          | 3.417676e+04|µg*h/l    |
|Raltegravir |AUC_norm     | 2.079086e+00|kg*h/l    |
|Raltegravir |AUC_inf      | 3.420447e+04|µg*h/l    |
|Raltegravir |AUC_inf_norm | 2.080772e+00|kg*h/l    |
|Raltegravir |MRT          | 4.095406e+00|h         |
|Raltegravir |Thalf        | 9.617984e+00|h         |
|Raltegravir |CL           | 8.009847e+00|ml/min/kg |
|Raltegravir |Vss          | 1.968214e+03|ml/kg     |
|Raltegravir |Vd           | 6.668591e+03|ml/kg     |


## 2.9. PK parameters for Raltegravir 1600 mg (lactose formulation)


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        | 1.979954e+04|µg/l      |
|Raltegravir |C_max_norm   | 9.033539e-01|kg/l      |
|Raltegravir |t_max        | 7.500000e-01|h         |
|Raltegravir |C_tEnd       | 2.665646e+00|µg/l      |
|Raltegravir |AUC          | 4.607060e+04|µg*h/l    |
|Raltegravir |AUC_norm     | 2.101971e+00|kg*h/l    |
|Raltegravir |AUC_inf      | 4.610762e+04|µg*h/l    |
|Raltegravir |AUC_inf_norm | 2.103660e+00|kg*h/l    |
|Raltegravir |MRT          | 4.125340e+00|h         |
|Raltegravir |Thalf        | 9.626328e+00|h         |
|Raltegravir |CL           | 7.922700e+00|ml/min/kg |
|Raltegravir |Vss          | 1.961030e+03|ml/kg     |
|Raltegravir |Vd           | 6.601758e+03|ml/kg     |


## 2.10. PK parameters for Raltegravir 100 mg filmcoated tablet md


|Path        |Parameter                    |        Value|Unit   |
|:-----------|:----------------------------|------------:|:------|
|Raltegravir |C_max                        |  893.8029417|µg/l   |
|Raltegravir |C_max_norm                   |    0.0326238|kg/l   |
|Raltegravir |C_max_t1_t2                  |  863.1595648|µg/l   |
|Raltegravir |C_max_t1_t2_norm             |    0.6301065|kg/l   |
|Raltegravir |C_max_tLast_tEnd             |  892.6807501|µg/l   |
|Raltegravir |C_max_tLast_tEnd_norm        |    0.6516570|kg/l   |
|Raltegravir |t_max                        |   84.7500000|h      |
|Raltegravir |t_max_t1_t2                  |    0.7500000|h      |
|Raltegravir |t_max_tLast_tEnd             |  228.7500000|h      |
|Raltegravir |C_trough_t2                  |   19.6617510|µg/l   |
|Raltegravir |C_trough_tLast               |   31.9226996|µg/l   |
|Raltegravir |AUC_t1_t2                    | 1978.7565232|µg*h/l |
|Raltegravir |AUC_t1_t2_norm               |    1.4444923|kg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast      | 2219.2012751|µg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast_norm |    1.6200169|kg*h/l |
|Raltegravir |AUC_inf_t1                   | 2144.3461704|µg*h/l |
|Raltegravir |AUC_inf_t1_norm              |    1.5653726|kg*h/l |
|Raltegravir |AUC_inf_tLast                | 2536.5938269|µg*h/l |
|Raltegravir |AUC_inf_tLast_norm           |    1.8517136|kg*h/l |
|Raltegravir |MRT                          |    3.9621429|h      |
|Raltegravir |Thalf                        |    5.8376226|h      |
|Raltegravir |Thalf_tLast_tEnd             |    6.9004822|h      |


## 2.11. PK parameters for Raltegravir 200 mg filmcoated tablet md


|Path        |Parameter                    |        Value|Unit   |
|:-----------|:----------------------------|------------:|:------|
|Raltegravir |C_max                        | 1810.3639857|µg/l   |
|Raltegravir |C_max_norm                   |    0.0330391|kg/l   |
|Raltegravir |C_max_t1_t2                  | 1748.6577478|µg/l   |
|Raltegravir |C_max_t1_t2_norm             |    0.6382601|kg/l   |
|Raltegravir |C_max_tLast_tEnd             | 1808.4366260|µg/l   |
|Raltegravir |C_max_tLast_tEnd_norm        |    0.6600794|kg/l   |
|Raltegravir |t_max                        |  180.7500000|h      |
|Raltegravir |t_max_t1_t2                  |    0.7500000|h      |
|Raltegravir |t_max_tLast_tEnd             |  228.7500000|h      |
|Raltegravir |C_trough_t2                  |   39.4742325|µg/l   |
|Raltegravir |C_trough_tLast               |   64.0288309|µg/l   |
|Raltegravir |AUC_t1_t2                    | 3998.1178427|µg*h/l |
|Raltegravir |AUC_t1_t2_norm               |    1.4593130|kg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast      | 4483.4029557|µg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast_norm |    1.6364421|kg*h/l |
|Raltegravir |AUC_inf_t1                   | 4329.1330307|µg*h/l |
|Raltegravir |AUC_inf_t1_norm              |    1.5801335|kg*h/l |
|Raltegravir |AUC_inf_tLast                | 5115.3598239|µg*h/l |
|Raltegravir |AUC_inf_tLast_norm           |    1.8671063|kg*h/l |
|Raltegravir |MRT                          |    3.9411664|h      |
|Raltegravir |Thalf                        |    5.8124568|h      |
|Raltegravir |Thalf_tLast_tEnd             |    6.8742091|h      |


## 2.12. PK parameters for Filmcoated_tablet_400mg_sd


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        | 3568.5563894|µg/l      |
|Raltegravir |C_max_norm   |    0.6512616|kg/l      |
|Raltegravir |t_max        |    0.7500000|h         |
|Raltegravir |C_tEnd       |   28.2685935|µg/l      |
|Raltegravir |AUC          | 8703.6498337|µg*h/l    |
|Raltegravir |AUC_norm     |    1.5884161|kg*h/l    |
|Raltegravir |AUC_inf      | 9072.4244034|µg*h/l    |
|Raltegravir |AUC_inf_norm |    1.6557174|kg*h/l    |
|Raltegravir |MRT          |    4.8922185|h         |
|Raltegravir |Thalf        |    9.0423584|h         |
|Raltegravir |CL           |   10.0661302|ml/min/kg |
|Raltegravir |Vss          | 2954.7424316|ml/kg     |
|Raltegravir |Vd           | 7878.9811134|ml/kg     |


## 2.13. PK parameters for Raltegravir 400 mg filmcoated tablet md


|Path        |Parameter                    |        Value|Unit   |
|:-----------|:----------------------------|------------:|:------|
|Raltegravir |C_max                        | 3.694358e+03|µg/l   |
|Raltegravir |C_max_norm                   | 3.371100e-02|kg/l   |
|Raltegravir |C_max_t1_t2                  | 3.569008e+03|µg/l   |
|Raltegravir |C_max_t1_t2_norm             | 6.513440e-01|kg/l   |
|Raltegravir |C_max_tLast_tEnd             | 3.689981e+03|µg/l   |
|Raltegravir |C_max_tLast_tEnd_norm        | 6.734216e-01|kg/l   |
|Raltegravir |t_max                        | 9.675000e+01|h      |
|Raltegravir |t_max_t1_t2                  | 7.500000e-01|h      |
|Raltegravir |t_max_tLast_tEnd             | 2.287500e+02|h      |
|Raltegravir |C_trough_t2                  | 7.975313e+01|µg/l   |
|Raltegravir |C_trough_tLast               | 1.291934e+02|µg/l   |
|Raltegravir |AUC_t1_t2                    | 8.128051e+03|µg*h/l |
|Raltegravir |AUC_t1_t2_norm               | 1.483369e+00|kg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast      | 9.098431e+03|µg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast_norm | 1.660464e+00|kg*h/l |
|Raltegravir |AUC_inf_t1                   | 8.798719e+03|µg*h/l |
|Raltegravir |AUC_inf_t1_norm              | 1.605766e+00|kg*h/l |
|Raltegravir |AUC_inf_tLast                | 1.036587e+04|µg*h/l |
|Raltegravir |AUC_inf_tLast_norm           | 1.891771e+00|kg*h/l |
|Raltegravir |MRT                          | 3.934582e+00|h      |
|Raltegravir |Thalf                        | 5.828885e+00|h      |
|Raltegravir |Thalf_tLast_tEnd             | 6.799025e+00|h      |


## 2.14. PK parameters for Raltegravir 400mg chewable fasted


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        |  6330.518996|µg/l      |
|Raltegravir |C_max_norm   |     1.155320|kg/l      |
|Raltegravir |t_max        |     0.750000|h         |
|Raltegravir |C_tEnd       |    35.836480|µg/l      |
|Raltegravir |AUC          | 14694.827674|µg*h/l    |
|Raltegravir |AUC_norm     |     2.681806|kg*h/l    |
|Raltegravir |AUC_inf      | 15124.213097|µg*h/l    |
|Raltegravir |AUC_inf_norm |     2.760169|kg*h/l    |
|Raltegravir |MRT          |     4.186335|h         |
|Raltegravir |Thalf        |     8.305142|h         |
|Raltegravir |CL           |     6.038278|ml/min/kg |
|Raltegravir |Vss          |  1516.695142|ml/kg     |
|Raltegravir |Vd           |  4340.961456|ml/kg     |


## 2.15. PK parameters for Raltegravir 400mg chewable fed


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        | 2.580439e+03|µg/l      |
|Raltegravir |C_max_norm   | 4.709301e-01|kg/l      |
|Raltegravir |t_max        | 2.500000e+00|h         |
|Raltegravir |C_tEnd       | 3.592768e+01|µg/l      |
|Raltegravir |AUC          | 1.411909e+04|µg*h/l    |
|Raltegravir |AUC_norm     | 2.576734e+00|kg*h/l    |
|Raltegravir |AUC_inf      | 1.460635e+04|µg*h/l    |
|Raltegravir |AUC_inf_norm | 2.665660e+00|kg*h/l    |
|Raltegravir |MRT          | 5.989332e+00|h         |
|Raltegravir |Thalf        | 9.400702e+00|h         |
|Raltegravir |CL           | 6.252361e+00|ml/min/kg |
|Raltegravir |Vss          | 2.246848e+03|ml/kg     |
|Raltegravir |Vd           | 5.087801e+03|ml/kg     |


## 2.16. PK parameters for Raltegravir 400mg (granules in suspension)


|Path        |Parameter    |        Value|Unit      |
|:-----------|:------------|------------:|:---------|
|Raltegravir |C_max        |  8156.789686|µg/l      |
|Raltegravir |C_max_norm   |     1.488614|kg/l      |
|Raltegravir |t_max        |     0.700000|h         |
|Raltegravir |C_tEnd       |    42.186887|µg/l      |
|Raltegravir |AUC          | 18791.010143|µg*h/l    |
|Raltegravir |AUC_norm     |     3.429359|kg*h/l    |
|Raltegravir |AUC_inf      | 19278.707122|µg*h/l    |
|Raltegravir |AUC_inf_norm |     3.518364|kg*h/l    |
|Raltegravir |MRT          |     4.020312|h         |
|Raltegravir |Thalf        |     8.013054|h         |
|Raltegravir |CL           |     4.737050|ml/min/kg |
|Raltegravir |Vss          |  1142.665029|ml/kg     |
|Raltegravir |Vd           |  3285.730123|ml/kg     |





# 3. Absorption


## 3.1. Absorption for Raltegravir 10 mg (lactose formulation)


\newpage
Figure 176: Absorption of Raltegravir


![](Absorption/Raltegravir%2010%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.2. Absorption for Raltegravir 25 mg (lactose formulation)


\newpage
Figure 177: Absorption of Raltegravir


![](Absorption/Raltegravir%2025%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.3. Absorption for Raltegravir 50 mg (lactose formulation)


\newpage
Figure 178: Absorption of Raltegravir


![](Absorption/Raltegravir%2050%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.4. Absorption for Raltegravir 100 mg (lactose formulation)


\newpage
Figure 179: Absorption of Raltegravir


![](Absorption/Raltegravir%20100%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.5. Absorption for Raltegravir 200 mg (lactose formulation)


\newpage
Figure 180: Absorption of Raltegravir


![](Absorption/Raltegravir%20200%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.6. Absorption for Raltegravir 400mg (lactose formulation)


\newpage
Figure 181: Absorption of Raltegravir


![](Absorption/Raltegravir%20400mg%20(lactose%20formulation)-Raltegravir.png)


## 3.7. Absorption for Raltegravir 800 mg (lactose formulation)


\newpage
Figure 182: Absorption of Raltegravir


![](Absorption/Raltegravir%20800%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.8. Absorption for Raltegravir 1200 mg (lactose formulation)


\newpage
Figure 183: Absorption of Raltegravir


![](Absorption/Raltegravir%201200%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.9. Absorption for Raltegravir 1600 mg (lactose formulation)


\newpage
Figure 184: Absorption of Raltegravir


![](Absorption/Raltegravir%201600%20mg%20(lactose%20formulation)-Raltegravir.png)


## 3.10. Absorption for Raltegravir 100 mg filmcoated tablet md


\newpage
Figure 185: Absorption of Raltegravir


![](Absorption/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-Raltegravir.png)


## 3.11. Absorption for Raltegravir 200 mg filmcoated tablet md


\newpage
Figure 186: Absorption of Raltegravir


![](Absorption/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-Raltegravir.png)


## 3.12. Absorption for Filmcoated_tablet_400mg_sd


\newpage
Figure 187: Absorption of Raltegravir


![](Absorption/Filmcoated_tablet_400mg_sd-Raltegravir.png)


## 3.13. Absorption for Raltegravir 400 mg filmcoated tablet md


\newpage
Figure 188: Absorption of Raltegravir


![](Absorption/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-Raltegravir.png)


## 3.14. Absorption for Raltegravir 400mg chewable fasted


\newpage
Figure 189: Absorption of Raltegravir


![](Absorption/Raltegravir%20400mg%20chewable%20fasted-Raltegravir.png)


## 3.15. Absorption for Raltegravir 400mg chewable fed


\newpage
Figure 190: Absorption of Raltegravir


![](Absorption/Raltegravir%20400mg%20chewable%20fed-Raltegravir.png)


## 3.16. Absorption for Raltegravir 400mg (granules in suspension)


\newpage
Figure 191: Absorption of Raltegravir


![](Absorption/Raltegravir%20400mg%20(granules%20in%20suspension)-Raltegravir.png)





# 4. Mass Balance


## 4.1. Mass Balance for Raltegravir 10 mg (lactose formulation)


\newpage
Figure 192: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%2010%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 193: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%2010%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 194: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%2010%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 195: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%2010%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 196: Fraction of drug  within the different compartments at 12h.


![](MassBalance/Raltegravir%2010%20mg%20(lactose%20formulation)-pieChart.png)


## 4.2. Mass Balance for Raltegravir 25 mg (lactose formulation)


\newpage
Figure 197: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%2025%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 198: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%2025%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 199: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%2025%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 200: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%2025%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 201: Fraction of drug  within the different compartments at 12h.


![](MassBalance/Raltegravir%2025%20mg%20(lactose%20formulation)-pieChart.png)


## 4.3. Mass Balance for Raltegravir 50 mg (lactose formulation)


\newpage
Figure 202: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%2050%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 203: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%2050%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 204: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%2050%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 205: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%2050%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 206: Fraction of drug  within the different compartments at 32h.


![](MassBalance/Raltegravir%2050%20mg%20(lactose%20formulation)-pieChart.png)


## 4.4. Mass Balance for Raltegravir 100 mg (lactose formulation)


\newpage
Figure 207: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20100%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 208: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20100%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 209: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20100%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 210: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20100%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 211: Fraction of drug  within the different compartments at 33h.


![](MassBalance/Raltegravir%20100%20mg%20(lactose%20formulation)-pieChart.png)


## 4.5. Mass Balance for Raltegravir 200 mg (lactose formulation)


\newpage
Figure 212: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20200%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 213: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20200%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 214: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20200%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 215: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20200%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 216: Fraction of drug  within the different compartments at 48h.


![](MassBalance/Raltegravir%20200%20mg%20(lactose%20formulation)-pieChart.png)


## 4.6. Mass Balance for Raltegravir 400mg (lactose formulation)


\newpage
Figure 217: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20400mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 218: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20400mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 219: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 220: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 221: Fraction of drug  within the different compartments at 48h.


![](MassBalance/Raltegravir%20400mg%20(lactose%20formulation)-pieChart.png)


## 4.7. Mass Balance for Raltegravir 800 mg (lactose formulation)


\newpage
Figure 222: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20800%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 223: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20800%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 224: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20800%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 225: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20800%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 226: Fraction of drug  within the different compartments at 50h.


![](MassBalance/Raltegravir%20800%20mg%20(lactose%20formulation)-pieChart.png)


## 4.8. Mass Balance for Raltegravir 1200 mg (lactose formulation)


\newpage
Figure 227: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%201200%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 228: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%201200%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 229: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%201200%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 230: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%201200%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 231: Fraction of drug  within the different compartments at 72h.


![](MassBalance/Raltegravir%201200%20mg%20(lactose%20formulation)-pieChart.png)


## 4.9. Mass Balance for Raltegravir 1600 mg (lactose formulation)


\newpage
Figure 232: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%201600%20mg%20(lactose%20formulation)-timeProfile.png)


\newpage
Figure 233: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%201600%20mg%20(lactose%20formulation)-cumulativeTimeProfile.png)


\newpage
Figure 234: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%201600%20mg%20(lactose%20formulation)-normalizedTimeProfile.png)


\newpage
Figure 235: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%201600%20mg%20(lactose%20formulation)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 236: Fraction of drug  within the different compartments at 72h.


![](MassBalance/Raltegravir%201600%20mg%20(lactose%20formulation)-pieChart.png)


## 4.10. Mass Balance for Raltegravir 100 mg filmcoated tablet md


\newpage
Figure 237: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-timeProfile.png)


\newpage
Figure 238: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-cumulativeTimeProfile.png)


\newpage
Figure 239: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-normalizedTimeProfile.png)


\newpage
Figure 240: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-normalizedCumulativeTimeProfile.png)


\newpage
Figure 241: Fraction of drug  within the different compartments at 240h.


![](MassBalance/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-pieChart.png)


## 4.11. Mass Balance for Raltegravir 200 mg filmcoated tablet md


\newpage
Figure 242: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-timeProfile.png)


\newpage
Figure 243: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-cumulativeTimeProfile.png)


\newpage
Figure 244: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-normalizedTimeProfile.png)


\newpage
Figure 245: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-normalizedCumulativeTimeProfile.png)


\newpage
Figure 246: Fraction of drug  within the different compartments at 240h.


![](MassBalance/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-pieChart.png)


## 4.12. Mass Balance for Filmcoated_tablet_400mg_sd


\newpage
Figure 247: Amount of drug vs time within the different compartments.


![](MassBalance/Filmcoated_tablet_400mg_sd-timeProfile.png)


\newpage
Figure 248: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Filmcoated_tablet_400mg_sd-cumulativeTimeProfile.png)


\newpage
Figure 249: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Filmcoated_tablet_400mg_sd-normalizedTimeProfile.png)


\newpage
Figure 250: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Filmcoated_tablet_400mg_sd-normalizedCumulativeTimeProfile.png)


\newpage
Figure 251: Fraction of drug  within the different compartments at 24h.


![](MassBalance/Filmcoated_tablet_400mg_sd-pieChart.png)


## 4.13. Mass Balance for Raltegravir 400 mg filmcoated tablet md


\newpage
Figure 252: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-timeProfile.png)


\newpage
Figure 253: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-cumulativeTimeProfile.png)


\newpage
Figure 254: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-normalizedTimeProfile.png)


\newpage
Figure 255: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-normalizedCumulativeTimeProfile.png)


\newpage
Figure 256: Fraction of drug  within the different compartments at 240h.


![](MassBalance/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-pieChart.png)


## 4.14. Mass Balance for Raltegravir 400mg chewable fasted


\newpage
Figure 257: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20400mg%20chewable%20fasted-timeProfile.png)


\newpage
Figure 258: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20400mg%20chewable%20fasted-cumulativeTimeProfile.png)


\newpage
Figure 259: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20chewable%20fasted-normalizedTimeProfile.png)


\newpage
Figure 260: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20chewable%20fasted-normalizedCumulativeTimeProfile.png)


\newpage
Figure 261: Fraction of drug  within the different compartments at 24h.


![](MassBalance/Raltegravir%20400mg%20chewable%20fasted-pieChart.png)


## 4.15. Mass Balance for Raltegravir 400mg chewable fed


\newpage
Figure 262: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20400mg%20chewable%20fed-timeProfile.png)


\newpage
Figure 263: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20400mg%20chewable%20fed-cumulativeTimeProfile.png)


\newpage
Figure 264: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20chewable%20fed-normalizedTimeProfile.png)


\newpage
Figure 265: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20chewable%20fed-normalizedCumulativeTimeProfile.png)


\newpage
Figure 266: Fraction of drug  within the different compartments at 24h.


![](MassBalance/Raltegravir%20400mg%20chewable%20fed-pieChart.png)


## 4.16. Mass Balance for Raltegravir 400mg (granules in suspension)


\newpage
Figure 267: Amount of drug vs time within the different compartments.


![](MassBalance/Raltegravir%20400mg%20(granules%20in%20suspension)-timeProfile.png)


\newpage
Figure 268: Cumulated amount of drug vs time within the different compartments


![](MassBalance/Raltegravir%20400mg%20(granules%20in%20suspension)-cumulativeTimeProfile.png)


\newpage
Figure 269: Amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20(granules%20in%20suspension)-normalizedTimeProfile.png)


\newpage
Figure 270: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass.


![](MassBalance/Raltegravir%20400mg%20(granules%20in%20suspension)-normalizedCumulativeTimeProfile.png)


\newpage
Figure 271: Fraction of drug  within the different compartments at 24h.


![](MassBalance/Raltegravir%20400mg%20(granules%20in%20suspension)-pieChart.png)





# 5. Time profiles and residual plots


## 5.1. Time profiles and residual plots for Raltegravir 10 mg (lactose formulation)


\newpage
Figure 272: Time profiles of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 273: Time profiles of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 274: Predicted vs observed of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 275: Predicted vs observed of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 276: Logarithmic residuals vs predicted values of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 277: Logarithmic residuals vs time of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 278: Logarithmic residuals distribution of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 279: Logarithmic residuals of Raltegravir 10 mg (lactose formulation) for Raltegravir 10 mg   (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2010%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.2. Time profiles and residual plots for Raltegravir 25 mg (lactose formulation)


\newpage
Figure 280: Time profiles of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 281: Time profiles of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 282: Predicted vs observed of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 283: Predicted vs observed of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 284: Logarithmic residuals vs predicted values of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 285: Logarithmic residuals vs time of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 286: Logarithmic residuals distribution of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 287: Logarithmic residuals of Raltegravir 25 mg (lactose formulation) for Raltegravir 25 mg  (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2025%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.3. Time profiles and residual plots for Raltegravir 50 mg (lactose formulation)


\newpage
Figure 288: Time profiles of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 289: Time profiles of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 290: Predicted vs observed of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 291: Predicted vs observed of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 292: Logarithmic residuals vs predicted values of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 293: Logarithmic residuals vs time of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 294: Logarithmic residuals distribution of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 295: Logarithmic residuals of Raltegravir 50 mg (lactose formulation) for Raltegravir 50 mg  (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%2050%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.4. Time profiles and residual plots for Raltegravir 100 mg (lactose formulation)


\newpage
Figure 296: Time profiles of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 297: Time profiles of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 298: Predicted vs observed of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 299: Predicted vs observed of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 300: Logarithmic residuals vs predicted values of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 301: Logarithmic residuals vs time of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 302: Logarithmic residuals distribution of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 303: Logarithmic residuals of Raltegravir 100 mg (lactose formulation) for Raltegravir 100 mg  (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.5. Time profiles and residual plots for Raltegravir 200 mg (lactose formulation)


\newpage
Figure 304: Time profiles of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 305: Time profiles of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 306: Predicted vs observed of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 307: Predicted vs observed of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 308: Logarithmic residuals vs predicted values of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 309: Logarithmic residuals vs time of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 310: Logarithmic residuals distribution of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 311: Logarithmic residuals of Raltegravir 200 mg (lactose formulation) for Raltegravir 200 mg   (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.6. Time profiles and residual plots for Raltegravir 400mg (lactose formulation)


\newpage
Figure 312: Time profiles of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 313: Time profiles of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 314: Predicted vs observed of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 315: Predicted vs observed of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 316: Logarithmic residuals vs predicted values of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 317: Logarithmic residuals vs time of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 318: Logarithmic residuals distribution of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 319: Logarithmic residuals of Raltegravir 400mg (lactose formulation) for Raltegravir 400mg (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.7. Time profiles and residual plots for Raltegravir 800 mg (lactose formulation)


\newpage
Figure 320: Time profiles of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 321: Time profiles of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 322: Predicted vs observed of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 323: Predicted vs observed of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 324: Logarithmic residuals vs predicted values of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 325: Logarithmic residuals vs time of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 326: Logarithmic residuals distribution of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 327: Logarithmic residuals of Raltegravir 800 mg (lactose formulation) for Raltegravir 800 mg  (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20800%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.8. Time profiles and residual plots for Raltegravir 1200 mg (lactose formulation)


\newpage
Figure 328: Time profiles of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 329: Time profiles of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 330: Predicted vs observed of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 331: Predicted vs observed of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 332: Logarithmic residuals vs predicted values of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 333: Logarithmic residuals vs time of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 334: Logarithmic residuals distribution of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 335: Logarithmic residuals of Raltegravir 1200 mg (lactose formulation) for Raltegravir 1200 mg   (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201200%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.9. Time profiles and residual plots for Raltegravir 1600 mg (lactose formulation)


\newpage
Figure 336: Time profiles of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 337: Time profiles of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 338: Predicted vs observed of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 339: Predicted vs observed of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 340: Logarithmic residuals vs predicted values of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 341: Logarithmic residuals vs time of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-resVsTime-totalRange.png)


\newpage
Figure 342: Logarithmic residuals distribution of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-resHisto-totalRange.png)


\newpage
Figure 343: Logarithmic residuals of Raltegravir 1600 mg (lactose formulation) for Raltegravir 1600 mg  (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%201600%20mg%20(lactose%20formulation)-resQQPlot-totalRange.png)


## 5.10. Time profiles and residual plots for Raltegravir 100 mg filmcoated tablet md


### 5.10.1. For total simulation time range


\newpage
Figure 344: Time profiles of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 345: Time profiles of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 346: Predicted vs observed of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 347: Predicted vs observed of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 348: Logarithmic residuals vs predicted values of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 349: Logarithmic residuals vs time of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resVsTime-totalRange.png)


\newpage
Figure 350: Logarithmic residuals distribution of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resHisto-totalRange.png)


\newpage
Figure 351: Logarithmic residuals of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resQQPlot-totalRange.png)


### 5.10.2. For first application range


\newpage
Figure 352: Time profiles of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-firstApplicationRange.png)


\newpage
Figure 353: Time profiles of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-firstApplicationRange.png)


### 5.10.3. For last application range


\newpage
Figure 354: Time profiles of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 355: Time profiles of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 356: Predicted vs observed of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-obsVsPred-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 357: Predicted vs observed of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-obsVsPredLog-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 358: Logarithmic residuals vs predicted values of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resVsPred-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 359: Logarithmic residuals vs time of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resVsTime-lastApplicationRange.png)


\newpage
Figure 360: Logarithmic residuals distribution of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resHisto-lastApplicationRange.png)


\newpage
Figure 361: Logarithmic residuals of Raltegravir 100 mg filmcoated tablet md for Raltegravir 100 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20100%20mg%20filmcoated%20tablet%20md-resQQPlot-lastApplicationRange.png)


## 5.11. Time profiles and residual plots for Raltegravir 200 mg filmcoated tablet md


### 5.11.1. For total simulation time range


\newpage
Figure 362: Time profiles of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 363: Time profiles of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 364: Predicted vs observed of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 365: Predicted vs observed of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 366: Logarithmic residuals vs predicted values of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 367: Logarithmic residuals vs time of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resVsTime-totalRange.png)


\newpage
Figure 368: Logarithmic residuals distribution of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resHisto-totalRange.png)


\newpage
Figure 369: Logarithmic residuals of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resQQPlot-totalRange.png)


### 5.11.2. For first application range


\newpage
Figure 370: Time profiles of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-firstApplicationRange.png)


\newpage
Figure 371: Time profiles of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-firstApplicationRange.png)


### 5.11.3. For last application range


\newpage
Figure 372: Time profiles of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 373: Time profiles of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 374: Predicted vs observed of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-obsVsPred-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 375: Predicted vs observed of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-obsVsPredLog-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 376: Logarithmic residuals vs predicted values of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resVsPred-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 377: Logarithmic residuals vs time of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resVsTime-lastApplicationRange.png)


\newpage
Figure 378: Logarithmic residuals distribution of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resHisto-lastApplicationRange.png)


\newpage
Figure 379: Logarithmic residuals of Raltegravir 200 mg filmcoated tablet md for Raltegravir 200 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20200%20mg%20filmcoated%20tablet%20md-resQQPlot-lastApplicationRange.png)


## 5.12. Time profiles and residual plots for Filmcoated_tablet_400mg_sd


\newpage
Figure 380: Time profiles of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 381: Time profiles of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 382: Predicted vs observed of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 383: Predicted vs observed of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 384: Logarithmic residuals vs predicted values of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 385: Logarithmic residuals vs time of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-resVsTime-totalRange.png)


\newpage
Figure 386: Logarithmic residuals distribution of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-resHisto-totalRange.png)


\newpage
Figure 387: Logarithmic residuals of Filmcoated_tablet_400mg_sd for Raltegravir 400mg filmcoated tablet as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Filmcoated_tablet_400mg_sd-resQQPlot-totalRange.png)


## 5.13. Time profiles and residual plots for Raltegravir 400 mg filmcoated tablet md


### 5.13.1. For total simulation time range


\newpage
Figure 388: Time profiles of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 389: Time profiles of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 390: Predicted vs observed of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 391: Predicted vs observed of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 392: Logarithmic residuals vs predicted values of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 393: Logarithmic residuals vs time of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resVsTime-totalRange.png)


\newpage
Figure 394: Logarithmic residuals distribution of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resHisto-totalRange.png)


\newpage
Figure 395: Logarithmic residuals of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resQQPlot-totalRange.png)


### 5.13.2. For first application range


\newpage
Figure 396: Time profiles of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-firstApplicationRange.png)


\newpage
Figure 397: Time profiles of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-firstApplicationRange.png)


### 5.13.3. For last application range


\newpage
Figure 398: Time profiles of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-timeProfile-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 399: Time profiles of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-timeProfileLog-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 400: Predicted vs observed of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-obsVsPred-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 401: Predicted vs observed of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-obsVsPredLog-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 402: Logarithmic residuals vs predicted values of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resVsPred-Concentration%20(molar)-lastApplicationRange.png)


\newpage
Figure 403: Logarithmic residuals vs time of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resVsTime-lastApplicationRange.png)


\newpage
Figure 404: Logarithmic residuals distribution of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resHisto-lastApplicationRange.png)


\newpage
Figure 405: Logarithmic residuals of Raltegravir 400 mg filmcoated tablet md for Raltegravir 400 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400%20mg%20filmcoated%20tablet%20md-resQQPlot-lastApplicationRange.png)


## 5.14. Time profiles and residual plots for Raltegravir 400mg chewable fasted


\newpage
Figure 406: Time profiles of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 407: Time profiles of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 408: Predicted vs observed of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 409: Predicted vs observed of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 410: Logarithmic residuals vs predicted values of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 411: Logarithmic residuals vs time of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-resVsTime-totalRange.png)


\newpage
Figure 412: Logarithmic residuals distribution of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-resHisto-totalRange.png)


\newpage
Figure 413: Logarithmic residuals of Raltegravir 400mg chewable fasted for Raltegravir 400mg chewable fasted as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fasted-resQQPlot-totalRange.png)


## 5.15. Time profiles and residual plots for Raltegravir 400mg chewable fed


\newpage
Figure 414: Time profiles of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 415: Time profiles of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 416: Predicted vs observed of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 417: Predicted vs observed of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 418: Logarithmic residuals vs predicted values of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 419: Logarithmic residuals vs time of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-resVsTime-totalRange.png)


\newpage
Figure 420: Logarithmic residuals distribution of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-resHisto-totalRange.png)


\newpage
Figure 421: Logarithmic residuals of Raltegravir 400mg chewable fed for Raltegravir 400mg chewable fed as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20chewable%20fed-resQQPlot-totalRange.png)


## 5.16. Time profiles and residual plots for Raltegravir 400mg (granules in suspension)


\newpage
Figure 422: Time profiles of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-timeProfile-Concentration%20(molar)-totalRange.png)


\newpage
Figure 423: Time profiles of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-timeProfileLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 424: Predicted vs observed of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-obsVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 425: Predicted vs observed of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-obsVsPredLog-Concentration%20(molar)-totalRange.png)


\newpage
Figure 426: Logarithmic residuals vs predicted values of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-resVsPred-Concentration%20(molar)-totalRange.png)


\newpage
Figure 427: Logarithmic residuals vs time of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-resVsTime-totalRange.png)


\newpage
Figure 428: Logarithmic residuals distribution of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-resHisto-totalRange.png)


\newpage
Figure 429: Logarithmic residuals of Raltegravir 400mg (granules in suspension) for Raltegravir 400mg (granules in suspension) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.


![](TimeProfiles/Raltegravir%20400mg%20(granules%20in%20suspension)-resQQPlot-totalRange.png)


## 5.17. Residuals across all simulations


\newpage
Figure 430: Distribution of residuals for Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 50 mg (lactose formulation), Raltegravir 100 mg (lactose formulation), Raltegravir 200 mg (lactose formulation), Raltegravir 400mg (lactose formulation), Raltegravir 800 mg (lactose formulation), Raltegravir 1200 mg (lactose formulation), Raltegravir 1600 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension)


![](TimeProfiles/residuals-histogram.png)


\newpage
Figure 431: Residuals for Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 50 mg (lactose formulation), Raltegravir 100 mg (lactose formulation), Raltegravir 200 mg (lactose formulation), Raltegravir 400mg (lactose formulation), Raltegravir 800 mg (lactose formulation), Raltegravir 1200 mg (lactose formulation), Raltegravir 1600 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension) as quantile-quantile plot.


![](TimeProfiles/residuals-qqplot.png)


